This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacKenzie, E. D.
Right arrow Articles by Gottlieb, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacKenzie, E. D.
Right arrow Articles by Gottlieb, E.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, May 2007, p. 3282-3289, Vol. 27, No. 9
0270-7306/07/$08.00+0     doi:10.1128/MCB.01927-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Cell-Permeating {alpha}-Ketoglutarate Derivatives Alleviate Pseudohypoxia in Succinate Dehydrogenase-Deficient Cells{triangledown}

Elaine D. MacKenzie,1,{dagger} Mary A. Selak,1,{dagger} Daniel A. Tennant,1 Lloyd J. Payne,3 Stuart Crosby,3 Casper M. Frederiksen,1,{ddagger} David G. Watson,2 and Eyal Gottlieb1*

Apoptosis and Tumour Physiology Laboratory, Cancer Research UK, The Beatson Institute for Cancer Research, Glasgow, United Kingdom,1 Department of Pharmaceutical Sciences, University of Strathclyde, Glasgow, United Kingdom,2 Tocris Cookson Ltd, Northpoint, Fourth Way, Avonmouth, Bristol BS11 8TA, United Kingdom3

Received 11 October 2006/ Returned for modification 15 November 2006/ Accepted 10 February 2007

Succinate dehydrogenase (SDH) and fumarate hydratase (FH) are components of the tricarboxylic acid (TCA) cycle and tumor suppressors. Loss of SDH or FH induces pseudohypoxia, a major tumor-supporting event, which is the activation of hypoxia-inducible factor (HIF) under normoxia. In SDH- or FH-deficient cells, HIF activation is due to HIF1{alpha} stabilization by succinate or fumarate, respectively, either of which, when in excess, inhibits HIF{alpha} prolyl hydroxylase (PHD). To reactivate PHD, we focused on its substrate, {alpha}-ketoglutarate. We designed and synthesized cell-permeating {alpha}-ketoglutarate derivatives, which build up rapidly and preferentially in cells with a dysfunctional TCA cycle. This study shows that succinate- or fumarate-mediated inhibition of PHD is competitive and is reversed by pharmacologically elevating intracellular {alpha}-ketoglutarate. Introduction of {alpha}-ketoglutarate derivatives restores normal PHD activity and HIF1{alpha} levels to SDH-suppressed cells, indicating new therapy possibilities for the cancers associated with TCA cycle dysfunction.


* Corresponding author. Mailing address: The Beatson Institute for Cancer Research, Switchback Road, Glasgow, Scotland G61 1BD, United Kingdom. Phone: 44 (0) 141 330 3981. Fax: 44 (0) 141 942 6521. E-mail: e.gottlieb{at}beatson.gla.ac.uk

{triangledown} Published ahead of print on 26 February 2007.

{dagger} E.D.M. and M.A.S. contributed equally to this work.

{ddagger} Present address: Center for Experimental Bioinformatics, University of Southern Denmark, Odense, Denmark.


Molecular and Cellular Biology, May 2007, p. 3282-3289, Vol. 27, No. 9
0270-7306/07/$08.00+0     doi:10.1128/MCB.01927-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Kaadige, M. R., Looper, R. E., Kamalanaadhan, S., Ayer, D. E. (2009). Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity. Proc. Natl. Acad. Sci. USA 106: 14878-14883 [Abstract] [Full Text]  
  • Mailloux, R. J., Singh, R., Brewer, G., Auger, C., Lemire, J., Appanna, V. D. (2009). {alpha}-Ketoglutarate Dehydrogenase and Glutamate Dehydrogenase Work in Tandem To Modulate the Antioxidant {alpha}-Ketoglutarate during Oxidative Stress in Pseudomonas fluorescens. J. Bacteriol. 191: 3804-3810 [Abstract] [Full Text]  
  • Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., Ding, J., Lei, Q., Guan, K.-L., Xiong, Y. (2009). Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1{alpha}. Science 324: 261-265 [Abstract] [Full Text]  
  • Thompson, C. B. (2009). Metabolic Enzymes as Oncogenes or Tumor Suppressors. NEJM 360: 813-815 [Full Text]  
  • Makowski, L., Noland, R. C., Koves, T. R., Xing, W., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., Muoio, D. M. (2009). Metabolic profiling of PPAR{alpha}-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB J. 23: 586-604 [Abstract] [Full Text]  
  • Qutub, A. A., Popel, A. S. (2008). Reactive Oxygen Species Regulate Hypoxia-Inducible Factor 1{alpha} Differentially in Cancer and Ischemia. Mol. Cell. Biol. 28: 5106-5119 [Abstract] [Full Text]